University of Michigan Medical Center
Locations
Transplant Summary
Overview
The University of Michigan’s BMT program averages 250 transplants each year-making us one of the largest programs in the state of Michigan. Our program is patient-focused, research-driven and internationally recognized for expertise in transplantation. Our Adult & Pediatric program has maintained FACT accreditation for the past 20 years and maintains a multidisciplinary approach to treating our BMT patients. Our medical teams are comprised of physician, nurse coordinators, physician assistants, social work, and pharmacists working together with insurance and financial teams to provide each patient the best care all in one hospital. In addition, we also have one of the best Extra Corporeal Photopheresis (ECP) programs in the state of Michigan that provides cutting-edge therapies to transplant patients with graft-vs.-host disease (GVHD).This center has been performing allogeneic transplants since 1990 and has been an NMDP transplant center since September 1994.
Attending physicians
Adult - Sarah Anand, Monalisa Ghosh, Darren King, John Maciejewski, John Magenau, Attaphol Pawarode, Dan Peltier, Pavan Reddy, Mary Riwes
Pediatric - Ghada Abusin, Sung Choi, Mark Vanderlugt, Gregory YanikTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Our program has been at the forefront of the development of CAR T-cell therapies for the past several years. Our program was 1 of 13 programs that participated in the CAR-T licensing trial for childhood ALL and 1 or 20 programs participating in the pivotal trial that led to FDA approval of diffuse large cell lymphoma for adults. Our BMT program has been the first in the state of Michigan to offer all the currently FDA-approved CAR T-cell therapies through Kymriah (Novartis) and Yescarta (Kite). Our Cellular Immunotherapy program is also very active in research efforts that include various CAR's, tumor cell vaccines, and cell-based therapies that utilize stem cells to create new tissues and gene therapies.
Patient Support Services are available throughout the course of the patient's treatment for BMT and CAR-t cell therapies: Patient and Family Research Center, Practical Assistance Services, Complimentary Therapy Programs, Psych Oncology Program, Counseling and Spiritual Services, Community Programs, Patient and Caregiver Support Services, BMT Nutritional Services, Fertility Services and easy communication with our medical staff via Michigan Medicine patient portal.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 316 patients.The actual 1-year survival of these patients is 75%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 72.3% and 81.1%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
454
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC72Cord blood0Total74Unrelated donorMarrow9PBSC133Cord blood2Total144Total allogeneicMarrow11PBSC205Cord blood2Total218AutologousMarrowBoth marrow & PBSC 236PBSC—Cord blood—Total236Total combinedMarrowBoth marrow & PBSC 452PBSC—Cord blood2Total454Total pediatric transplants
69
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow18PBSC4Cord blood1Total23Unrelated donorMarrow11PBSC0Cord blood2Total13Total allogeneicMarrow29PBSC4Cord blood3Total36AutologousMarrowBoth marrow & PBSC 33PBSC—Cord blood—Total33Total combinedMarrowBoth marrow & PBSC 66PBSC—Cord blood3Total69All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-182319-441945-643765+18Total97Unrelated 0-181419-443445-645565+54Total157Autologous 0-183319-443545-6412165+80Total269Total 0-187019-448845-6421365+152Total523Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.